Back
33
Also listed as
SONVF
OTC
Day Range
$42.39
$43.80
52-Week Range
$42.39
$68.76
Volume
9,206
50D / 200D Avg
$52.03
/
$54.86
Prev Close
$44.79
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 23.7 | 0.4 |
| P/B | 4.8 | 2.9 |
| ROE % | 21.1 | 3.7 |
| Net Margin % | 14.0 | 3.8 |
| Rev Growth 5Y % | 10.4 | 10.0 |
| D/E | 0.7 | 0.2 |
Key Takeaways
Revenue grew 10.40% annually over 5 years — strong growth
Earnings declined -10.07% over the past year
ROE of 21.05% indicates high profitability
Generating 656.10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.82%
Cash machine — converts 121.39% of earnings into free cash flow
Growth
Revenue Growth (5Y)
10.40%
Revenue (1Y)6.58%
Earnings (1Y)-10.07%
FCF Growth (3Y)3.79%
Quality
Return on Equity
21.05%
ROIC11.73%
Net Margin13.98%
Op. Margin17.90%
Safety
Debt / Equity
0.66
Current Ratio1.27
Interest Coverage26.11
Valuation
P/E Ratio
23.66
P/B Ratio4.80
EV/EBITDA20.04
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.58% | Revenue Growth (3Y) | 1.68% |
| Earnings Growth (1Y) | -10.07% | Earnings Growth (3Y) | -8.64% |
| Revenue Growth (5Y) | 10.40% | Earnings Growth (5Y) | -1.79% |
| Profitability | |||
| Revenue (TTM) | 3.87B | Net Income (TTM) | 540.50M |
| ROE | 21.05% | ROA | 9.12% |
| Gross Margin | 72.04% | Operating Margin | 17.90% |
| Net Margin | 13.98% | Free Cash Flow (TTM) | 656.10M |
| ROIC | 11.73% | FCF Growth (3Y) | 3.79% |
| Safety | |||
| Debt / Equity | 0.66 | Current Ratio | 1.27 |
| Interest Coverage | 26.11 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 23.66 | P/B Ratio | 4.80 |
| P/S Ratio | 3.31 | PEG Ratio | -2.90 |
| EV/EBITDA | 20.04 | Dividend Yield | 0.02% |
| Market Cap | 12.79B | Enterprise Value | 13.86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.87B | 3.63B | 3.74B | 3.36B | 2.60B |
| Net Income | 540.50M | 601.00M | 647.50M | 649.00M | 581.00M |
| EPS (Diluted) | 1.81 | 2.01 | 2.14 | 2.07 | 1.84 |
| Gross Profit | 2.78B | 2.62B | 2.59B | 2.42B | 1.84B |
| Operating Income | 691.90M | 669.90M | 761.80M | 785.10M | 559.20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.92B | 5.79B | 5.55B | 5.59B | 5.93B |
| Total Liabilities | 3.24B | 3.30B | 3.32B | 3.16B | 3.15B |
| Shareholders' Equity | 2.66B | 2.47B | 2.21B | 2.41B | 2.75B |
| Total Debt | 1.76B | 1.79B | 1.81B | 1.48B | 1.83B |
| Cash & Equivalents | 686.90M | 513.60M | 413.90M | 610.50M | 1.77B |
| Current Assets | 1.91B | 1.65B | 1.51B | 1.66B | 2.62B |
| Current Liabilities | 1.50B | 1.14B | 1.10B | 1.51B | 1.25B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#753 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026